Coronary artery disease/multi-vessel disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a) patients with stable angina who are candidate for the revascularization with PCI or CABG b) patients with multi-vessel disease (=>2 vessels) including left anterior descending artery (AHA classification #6 and/or #7) c) patients in which the respecified projection protocol for QFR analysis is available
Exclusion criteria
Exclusion criteria: a) patients with a stenosis in left main coronary artery or ostial right coronary artery (=<3mm) b) post-CABG patients c) patients with chronic kidney disease or hemodialysis d) patients with anatomical condition inappropriate for QFR analysis e) patients with medicine provoking hyperaemia (adenosine) f) patients who can not consent with a written document
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The agreement of the treatment decision (CABG-only or PCI-only/equipoise) between QFR-based discussion and FFR-based discussion (Cohen's Kappa) | — |
Secondary
| Measure | Time frame |
|---|---|
| The agreement of the treatment decision of QFR-based discussion between before and after unblinding of the functional SYNATX score derived from FFR (Cohen's Kappa) The agreement of the treatment decision (CABG-only or PCI-only/equipoise ) between QFR-based discussion and FFR-based discussion after unblinding (Cohen's Kappa) | — |
Countries
Japan
Contacts
St. Luke's International Hospital Cardiology